| Cat.No. | Name | Information |
|---|---|---|
| M6098 | Baicalein | Baicalein is a CYP2C9 and prolyl endopeptidase inhibitor, IC50 value of 3.12 mM. |
| M9325 | EGTA | EGTA is a specific calcium chelator with a Kd of 60.5 nM at physiological pH (7.4) and a high specificity for Ca2+ than for Mg2+.EGTA significantly inhibits the substrate adhesion capacity of inflammatory macrophages. |
| M9330 | Brij-35 | Brij-35 (Polidocanol) is a high HLB, ethoxylated, nonionic ether of lauryl alcohol with broad pH stability. |
| M6154 | 2-PMPA tetrasodium | 2-PMPA (PMPA tetrasodium salt) is a potent and selective inhibitor of glutamate carboxypeptidase II (GCPII) with an IC50 of 300 pM. |
| M2250 | Pamidronate disodium | Pamidronate disodium is a nitrogen containing bisphosphonate, used to the research of preventing osteoporosis. |
| M9916 | DPPH | DPPH (2,2-Diphenyl-1-picrylhydrazyl) is a stable free radical that measures the free radical scavenging activity of antioxidants. |
| M9194 | Insulin (human) | Insulin (human) is a polypeptide hormone that regulates the level of sugar (glucose) in the blood and is produced by beta cells of islets. |
| M3409 | Formestane | Formestane is a second generation selective aromatase inhibitor with an IC50 of 80 nM. |
| M9665 | N-(2-amino-2-oxoethyl)acrylamide | N-(2-Amino-2-oxoethyl)acrylamide |
| M7791 | Exo-1 | Exo1 is a reversible inhibitor of exocytosis, also a Golgi ARF 1 (ADP-Ribosylation Factor) GTPase activator. |
| M42532 | BC-05 | BC-05 is an orally active and potent inhibitor of CD13 and proteasome. |
| M42447 | HPPD-IN-1 | HPPD-IN-1 is a HPPD inhibitor. |
| M42433 | PROTAC HK2 Degrader-1 | PROTAC HK2 Degrader-1 is a PROTAC consisting of Lonidamine as a target protein Hexokinase 2 (HK2) inhibitor and Thalidomide as a CRBN ligand-linked PROTAC. |
| M42308 | Acid Ceramidase-IN-2 | Acid Ceramidase-IN-2 is an acid ceramidase inhibitor with potentially antiproliferative and cytostatic activities. |
| M42300 | Mergetpa | Mergetpa is a carboxypeptidase inhibitor used to block the conversion of kinins and B2 receptor antagonists to metabolites lacking the C-terminal arginine. |
| M42291 | Forrestiacids J | Forrestiacids J is an ATP-citrate lyase (ACL) inhibitor with an IC50 of 2.6 μM. |
| M42290 | Forrestiacids K | Forrestiacids K, a terpenoid isolated from Pseudotsuga forrestii, acts as an ATP-citrate lyase (ACL) inhibitor. |
| M42284 | α‑Amylase-IN-1 | α Amylase-IN-1 is an α-Amylase inhibitor with an IC50 value of 0.5509 μM. |
| M42276 | MK 386 | MK 386 (L-733692) is a selective 5-α-reductase I inhibitor, used for prostate cancer inhibition. |
| M42271 | PU-48 | PU-48 is a potent urea transporters A (UT-A) inhibitor (IC50=0.32 μM). |
| M41951 | Urotensin II-related peptide | Urotensin II-related peptide is a human urotensin II anague. |
| M41950 | GSK 1562590 hydrochloride | GSK 1562590 hydrochloride is a high affinity and selective antagonist of urotensin-II receptor (UT), with pKis of 9.14-9.66 for mammalian recombinant (mouse, rat, cat, monkey, human) and native UT. |
| M41949 | SUCNR1-IN-1 | SUCNR1-IN-1 is a SUCNR1 inhibitor (IC50: 88 nM for hSUCNR1). |
| M41939 | BMS-192364 | BMS-192364 is targeting the Gα-RGS interaction to produce an inactive Gα-RGS complex. |
| M41878 | Atilmotin | OHM 11638 (Atilmotin), an analogue of the (1-14) fragment of porcine motilin, is a motilin receptor agonist with a pKd of 8.94 for the motilin receptor. |
| M41824 | GRK6-IN-3 | GRK6-IN-3 is a G protein coupled receptor 6 kinase (GRK6) inhibitor with an IC50 1.03 μM. |
| M41823 | TGR5 agonist 2 | TGR5 agonist 2 is a potent TGR5 agonist with an EC50 value of 0.27 µM. |
| M41822 | TGR5 agonist 1 | TGR5 agonist 1 is a potent TGR5 agonist with an EC50 value of 0.31 µM. |
| M41818 | LTB4-IN-2 | LTB4-IN-2 (Comopund 6x) is a Leukotriene B4 (LTB4) inhibitor. |
| M41634 | DKI5 | DKI5, also known as (E)-N’-benzylidenehydrazinecarbothiohydrazide, is a LOX-1 inhibitor with an IC50 value of 22.5 μM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.
